Microbial electrolysis cells for decentralisedwastewater treatment: The next steps

Traditional wastewater treatment methods have become aged and inefficient, meaning alternative methods are essential to protect the environment and ensure water and energy security worldwide. The use of microbial electrolysis cells (MEC) for wastewater treatment provides an innovative alternative, working towards circular wastewater treatment for energy production. This study evaluates the factors hindering industrial adoption of this technology and proposes the next steps for further research and development. Existing pilot-scale investigations are studied to critically assess the main limitations, focusing on the electrode material, feedstock, system design and inoculation and what steps need to be taken for industrial adoption of the technology. It was found that high strength influents lead to an increase in energy production, improving economic viability; however, large variations in waste streams indicated that a homogenous solution to wastewater treatment is unlikely with changes to the MEC system specific to different waste streams. The current capital cost of implementing MECs is high and reducing the cost of the electrodes should be a priority. Previous pilot-scale studies have predominantly used carbon-based materials. Significant reductions in relative performance are observed when electrodes increase in size. Inoculation time was found to be a significant barrier to quick operational performance. Economic analysis of the technology indicated that MECs offer an attractive option for wastewater treatment, namely greater energy production and improved treatment efficiency. However, a significant reduction in capital cost is necessary to make this economically viable. MEC based systems should offer improvements in system reliability, reduced downtime, improved treatment rates and improved energy return. Discussion of the merits of H2 or CH4 production indicates that an initial focus on methane production could provide a stepping-stone in the adoption of this technology while the hydrogen market matures.Engineering and Physical Sciences Research Council; London South Bank University and the European Regional Development Fun

Lysozyme transgenic goats’ milk positively impacts intestinal cytokine expression and morphology

In addition to its well-recognized antimicrobial properties, lysozyme can also modulate the inflammatory response. This ability may be particularly important in the gastrointestinal tract where inappropriate inflammatory reactions can damage the intestinal epithelium, leading to significant health problems. The consumption of milk from transgenic goats producing human lysozyme (hLZ) in their milk therefore has the potential to positively impact intestinal health. In order to investigate the effect of hLZ-containing milk on the inflammatory response, young pigs were fed pasteurized milk from hLZ or non-transgenic control goats and quantitative real-time PCR was performed to assess local expression of TNF-α, IL-8, and TGF-β1 in the small intestine. Histological changes were also investigated, specifically looking at villi width, length, crypt depth, and lamina propria thickness along with cell counts for intraepithelial lymphocytes and goblet cells. Significantly higher expression of anti-inflammatory cytokine TGF-β1 was seen in the ileum of pigs fed pasteurized milk containing hLZ (P = 0.0478), along with an increase in intraepithelial lymphocytes (P = 0.0255), and decrease in lamina propria thickness in the duodenum (P = 0.0001). Based on these results we conclude that consuming pasteurized milk containing hLZ does not induce an inflammatory response and improves the health of the small intestine in pigs